The latest report titled ‘Global
In-Vitro Diagnostics Market,’ published by Emergen Research, provides the reader with a comprehensive view of the global In-Vitro Diagnostics industry, acquainting them with the latest market trends, industry insights, and market share. The latest report offers a profound analysis of the present market scenario, its key product types, end-user landscape, application outlook, leading regions, competitive terrain, and the leading companies’ detailed profiles.
The global In-Vitro Diagnostics (IVD) market size is expected to reach USD 118.44 Billion at a steady revenue CAGR of 4.4% in 2028, according to latest analysis by Emergen Research. In-vitro diagnostics market revenue growth is due to increased investment in research & development in genomics and proteomics, and rising prevalence of targeted diseases.
The study performs a historical assessment of the In-Vitro Diagnostics, focusing on the market trends, revenue share, growth rate, production capacity, pricing structure, and other vital aspects during that period. The report emphasizes the demands and ongoing trends of the global In-Vitro Diagnostics market, more importantly, across the major regions of the market. Additionally, our analysts have included SWOT analysis and Porter’s Five Forces analysis in the report to offer a better understanding of the competitive spectrum of this ever-evolving industry. Moreover, the report sheds light on the cutting-edge expansion strategies adopted by the market contenders, such as mergers & acquisitions, joint ventures, partnerships & collaborations, new product launches, and brand promotions.
Research Report on the In-Vitro Diagnostics Market Addresses the Following Key Questions:
- Who are the dominant players of the In-Vitro Diagnostics market?
- Which regional market is anticipated to have a high growth rate over the projected period?
- What consumer trends and demands are expected to influence the operations of the market players in the In-Vitro Diagnostics market?
- What are the key growth drivers and restraining factors of the In-Vitro Diagnostics market?
- What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
- What is the overall impact of the COVID-19 pandemic on the In-Vitro Diagnostics market and its key segments?
The global In-Vitro Diagnostics market consists of various segments, including product type outlook, application spectrum, end-user overview, leading regions, and the competitive analysis. The report further provides information regarding the value chain, emerging market sectors, and the technological advancements in the industry to benefit readers and businesses looking to invest in this industry.
Key Market Competitors Profiled in the Report:
Siemens Healthineers, Roche Diagnostics, Danaher Corporation, bioMérieux, Abbott Laboratories, DiaSorin, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, QIAGEN, and Sysmex Corporation
Major Geographies Covered in the Report:
- North America (US, Canada)
- Europe (UK, Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of MEA)
Market Segmentations of the In-Vitro Diagnostics Market
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the forecast period. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global In-Vitro Diagnostics market on the basis of product, application, and region:
Segments Covered in this report are:
- Product Outlook (Revenue, USD Billion; 2018–2028)
- Reagents & Kits
- Instruments
- Fully Automated Instruments
- Semi-Automated Instruments
- Data Management Software
- Services
- Devices Outlook (Revenue, USD Billion; 2018–2028)
- Reusable IVD Devices
- Disposable IVD Devices
- Application Outlook (Revenue, USD Billion; 2018–2028)
- Cancer
- Infectious Diseases
- Diabetes
- Gastrointestinal Disease
- Autoimmune Diseases
- Cardiac Disease
- Drug Testing /Pharmacogenomics
- HIV/AIDS
- Nephrological Disease
- Others
Target Audience of the Report:
- Leading Companies
- Large, medium-sized, and small enterprises
- Investors
- Value-Added Resellers (VARs)
- Venture capitalists
- Third-party knowledge providers
โพสต์ 2024-3-16 16:29:00